Baseline characteristics
Characteristic . | VWD patients (n = 658) . | |
---|---|---|
No. . | % . | |
Age, y | ||
Median | 43.5 | |
Range | 1-83 | |
Male sex | 251 | 38 |
VWD type | ||
1 | 380 | 58 |
2 | 241 | 37 |
2A | 158 | |
2B | 42 | |
2M | 27 | |
2N | 14 | |
3 | 37 | 6 |
Blood group O* | 398 | 61 |
VWF:Ag (IU/dL) | ||
Median | 29 | |
25%-75% IQR | 18-45 | |
VWF:Act (U/dL) | ||
Median | 22 | |
25%-75% IQR | 8-53 | |
FVIII:C (IU/dL) | ||
Median | 51 | |
25%-75% IQR | 32-73 | |
BS† | ||
Median | 11 | |
25%-75% IQR | 6-16 |
Characteristic . | VWD patients (n = 658) . | |
---|---|---|
No. . | % . | |
Age, y | ||
Median | 43.5 | |
Range | 1-83 | |
Male sex | 251 | 38 |
VWD type | ||
1 | 380 | 58 |
2 | 241 | 37 |
2A | 158 | |
2B | 42 | |
2M | 27 | |
2N | 14 | |
3 | 37 | 6 |
Blood group O* | 398 | 61 |
VWF:Ag (IU/dL) | ||
Median | 29 | |
25%-75% IQR | 18-45 | |
VWF:Act (U/dL) | ||
Median | 22 | |
25%-75% IQR | 8-53 | |
FVIII:C (IU/dL) | ||
Median | 51 | |
25%-75% IQR | 32-73 | |
BS† | ||
Median | 11 | |
25%-75% IQR | 6-16 |